The 12-Year Experience of the Hungarian Pancreatic Study Group

Szentesi, Andrea and Hegyi, Péter (2025) The 12-Year Experience of the Hungarian Pancreatic Study Group. JOURNAL OF CLINICAL MEDICINE, 14 (4). No. 1362. ISSN 2077-0383

Preview

Text jcm-14-01362-v2.pdf - Published Version Available under License Creative Commons Attribution. Download (564kB) | Preview

Abstract

The Hungarian Pancreatic Study Group (HPSG) was established with the aim of advancing pancreatology. Our summary outlines the methodologies, key results, and future directions of the HPSG. Methodological elements included, the formation of strategic national and international collaborations, the establishment of patient registries and biobanks, and a strong focus on education and guideline development. Key results encompassed, pioneering research on pancreatic ductal function and the role of cystic fibrosis transmembrane conductance regulator (CFTR) in inflammation, significant advancements in understanding acute and chronic pancreatitis, and the execution of numerous clinical trials to explore new therapeutic approaches. Despite challenges, such as securing funding and translating research into clinical practice, the HPSG’s commitment to patient care and scientific innovation has been unwavering. The group aims to deepen research into pancreatic cancer and chronic pancreatitis, conduct more randomized controlled trials (RCTs), and expand its efforts internationally by involving global staff and patients. The authors hope that this summary inspires others to undertake similar initiatives and contribute to the global advancement of medical research and patient care in pancreatology.

Actions (login required)

Edit Item